The TAB1-p38a complex is a therapeutic target in acute myocardial ischemia: the holy grail of circumstance selective inhibition of p38a.
20 April 2018 (18:20 - 18:30)
Organised by: 
Abstract
Slides
About the speaker
King's College London, London (United Kingdom of Great Britain & Northern Ireland)
5 More presentations in this session
Professor F. Recchia (Pisa, IT)
Professor P. Ferdinandy (Budapest, HU)
Doctor A. Akhmedov (Zurich, CH)
Access the full session
The Event
Frontiers in CardioVascular Biology 2018
20 April 2018
18:20 CET
